“Single-center, non-randomized, prospective phase II study evaluating the effectiveness of induction chemoimmunotherapy in the combined outcome of locally advanced non-small cell lung disease” (2025) Voprosy onkologii, 71(6), p. OF-2369. doi:10.37469/0507-3758-2025-71-6-OF-2369.